Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 Oct;37(10):2173–2178. doi: 10.1128/aac.37.10.2173

Mechanistic study of inhibition of levofloxacin absorption by aluminum hydroxide.

M Tanaka 1, T Kurata 1, C Fujisawa 1, Y Ohshima 1, H Aoki 1, O Okazaki 1, H Hakusui 1
PMCID: PMC192246  PMID: 8257141

Abstract

The mechanisms of reduction in absorption of levofloxacin (LVFX) by coadministration of aluminum hydroxide were studied. The partition coefficient of LVFX (0.1 mM) between chloroform and phosphate buffer (pH 5.0) was reduced by 60 to 70% with the addition of metal ions such as Cu2+, Al3+, and Fe2+ (0.8 mM), which indicated the formation of LVFX-metal ion chelates. However, there was no significant difference in absorption from rat intestine between the synthetic LVFX-Al3+ (1:1) chelate (6.75 mM) and LVFX (6.75 mM) in an in situ recirculation experiment. On the other hand, Al(NO3)3 (1.5 mM) significantly inhibited the absorption of LVFX (1.5 mM) by 20% of the control in the in situ ligated loop experiment, in which partial precipitation of aluminum hydroxide was observed in the dosing solution. Data for adsorption of LVFX and ofloxacin (OFLX) from aqueous solution by aluminum hydroxide were shown to fit Langmuir plots, and the adsorptive capacities (rmax) and the K values were 7.0 mg/g and 1.77 x 10(4) M-1 for LVFX and 7.4 mg/g and 1.42 x 10(4) M-1 for OFLX, respectively. The rate of adsorption of several quinolones (50 microM) onto aluminum hydroxide (2.5 mg/ml) followed the order norfloxacin (NFLX) (72.0%) > enoxacin (ENX) (61.0%) > OFLX (47.2%) approximately LVFX (48.1%). The elution rate of adsorbed quinolones with water followed the rank order LVFX (17.9%) approximately OFLX (20.9%) approximately ENX (18.3%) > NFLX (11.9%). These results strongly suggest that adsorption of quinolones by aluminum hydroxide reprecipitated in the small intestine would play an important role in the reduced bioavailability of quinolones after coadministration with aluminum-containing antacids.

Full text

PDF
2173

Images in this article

2176Image
on p.2176

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLAUG S. M., GROSS M. R. IN VITRO ADSORPTION OF SOME ANTICHOLINERGIC DRUGS BY VARIOUS ANTACIDS. J Pharm Sci. 1965 Feb;54:289–294. doi: 10.1002/jps.2600540227. [DOI] [PubMed] [Google Scholar]
  2. Bagnall W. E., Kelleher J., Walker B. E., Losowsky M. S. The gastrointestinal absorption of paracetamol in the rat. J Pharm Pharmacol. 1979 Mar;31(3):157–160. doi: 10.1111/j.2042-7158.1979.tb13459.x. [DOI] [PubMed] [Google Scholar]
  3. Campbell N. R., Kara M., Hasinoff B. B., Haddara W. M., McKay D. W. Norfloxacin interaction with antacids and minerals. Br J Clin Pharmacol. 1992 Jan;33(1):115–116. doi: 10.1111/j.1365-2125.1992.tb04010.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Clain J. E., Malagelada J. R., Chadwick V. S., Hofmann A. F. Binding properties in vitro of antacids for conjugated bile acids. Gastroenterology. 1977 Sep;73(3):556–559. [PubMed] [Google Scholar]
  5. Hayakawa I., Atarashi S., Yokohama S., Imamura M., Sakano K., Furukawa M. Synthesis and antibacterial activities of optically active ofloxacin. Antimicrob Agents Chemother. 1986 Jan;29(1):163–164. doi: 10.1128/aac.29.1.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hem S. L., White J. L., Buehler J. D., Luber J. R., Grim W. M., Lipka E. A. Evaluation of antacid suspensions containing aluminum hydroxide and magnesium hydroxide. Am J Hosp Pharm. 1982 Nov;39(11):1925–1930. [PubMed] [Google Scholar]
  7. Issopoulos P. B. Spectrophotometric determination of trace amounts of iron(III) with norfloxacin as complexing reagent. Analyst. 1989 May;114(5):627–630. doi: 10.1039/an9891400627. [DOI] [PubMed] [Google Scholar]
  8. KOIZUMI T., ARITA T., KAKEMI K. ABSORPTION AND EXCRETION OF DRUGS. XX. SOME PHARMACOKINETIC ASPECTS OF ABSORPTION AND EXCRETION OF SULFONAMIDES. (2). ABSORPTION FROM RAT SMALL INTESTINE. Chem Pharm Bull (Tokyo) 1964 Apr;12:421–427. doi: 10.1248/cpb.12.421. [DOI] [PubMed] [Google Scholar]
  9. Khalil S. A., Daabis N. A., Naggar V. F., Motawi M. M. The in vitro adsorption of some antibiotics on antacids. Pharmazie. 1976;31(2):105–109. [PubMed] [Google Scholar]
  10. Lomaestro B. M., Bailie G. R. Quinolone-cation interactions: a review. DICP. 1991 Nov;25(11):1249–1258. doi: 10.1177/106002809102501115. [DOI] [PubMed] [Google Scholar]
  11. Mangnall Y. F., Smythe A., Johnson A. G. The ability of antacids and cholestyramine to bind bile acids: effect of pH. Scand J Gastroenterol. 1986 Sep;21(7):789–794. doi: 10.3109/00365528609011118. [DOI] [PubMed] [Google Scholar]
  12. Merino M., Polache A., Peris-Ribera J. E., Moreno-Dalmau J., Plá-Delfina J. M. Absorption kinetics of beta-alanine as model compound in rat small intestine. Biochim Biophys Acta. 1989 Nov 17;986(1):1–7. doi: 10.1016/0005-2736(89)90264-2. [DOI] [PubMed] [Google Scholar]
  13. Nakano M., Yamamoto M., Arita T. Interactions of aluminum, magnesium, and calcium ions with nalidixic acid. Chem Pharm Bull (Tokyo) 1978 May;26(5):1505–1510. doi: 10.1248/cpb.26.1505. [DOI] [PubMed] [Google Scholar]
  14. Okazaki O., Aoki H., Hakusui H. High-performance liquid chromatographic determination of (S)-(-)-ofloxacin and its metabolites in serum and urine using a solid-phase clean-up. J Chromatogr. 1991 Feb 15;563(2):313–322. doi: 10.1016/0378-4347(91)80037-d. [DOI] [PubMed] [Google Scholar]
  15. Partridge N. A., Regnier F. E., White J. L., Hem S. L. Influence of dietary constituents on intestinal absorption of aluminum. Kidney Int. 1989 Jun;35(6):1413–1417. doi: 10.1038/ki.1989.142. [DOI] [PubMed] [Google Scholar]
  16. Sato K., Matsuura Y., Inoue M., Une T., Osada Y., Ogawa H., Mitsuhashi S. In vitro and in vivo activity of DL-8280, a new oxazine derivative. Antimicrob Agents Chemother. 1982 Oct;22(4):548–553. doi: 10.1128/aac.22.4.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Shiba K., Sakai O., Shimada J., Okazaki O., Aoki H., Hakusui H. Effects of antacids, ferrous sulfate, and ranitidine on absorption of DR-3355 in humans. Antimicrob Agents Chemother. 1992 Oct;36(10):2270–2274. doi: 10.1128/aac.36.10.2270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Shimada J., Shiba K., Oguma T., Miwa H., Yoshimura Y., Nishikawa T., Okabayashi Y., Kitagawa T., Yamamoto S. Effect of antacid on absorption of the quinolone lomefloxacin. Antimicrob Agents Chemother. 1992 Jun;36(6):1219–1224. doi: 10.1128/aac.36.6.1219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tsuji A., Miyamoto E., Kagami I., Sakaguchi H., Yamana T. GI absorption of beta-lactam antibiotics I: kinetic assessment of competing absorption and degradation in GI tract. J Pharm Sci. 1978 Dec;67(12):1701–1704. doi: 10.1002/jps.2600671218. [DOI] [PubMed] [Google Scholar]
  20. Une T., Fujimoto T., Sato K., Osada Y. In vitro activity of DR-3355, an optically active ofloxacin. Antimicrob Agents Chemother. 1988 Sep;32(9):1336–1340. doi: 10.1128/aac.32.9.1336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. el-Masry S., Khalil S. A. Adsorption of atropine and hyoscine on magnesium trisilicate. J Pharm Pharmacol. 1974 Apr;26(4):243–248. doi: 10.1111/j.2042-7158.1974.tb09265.x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES